Table 5.
Author | Year | Women | Pregnancy | Palpitation | Syncope/dizziness | Arrhythmia | HF | CS | Deaths | Diuretic | BB | Antiarrhythmic | ICD |
Bauce et al 40 | 2006 | 6 | 6 | 2 (33) | NA | 2 (33) VES. 1 (17) VT postpartum. |
NA | 4 (67) | 0 | NA | 2 (33) | 2 (33) propafenone. 2 (33) flecainide. |
1 (17) |
Hodes et al 41 | 2016 | 26 | 39 | 7 (27) | NA | 5 (19) SVA. | 2 (8) | 11 (28) | 0 | 3 (12) | 16 (62) | 1 (4) flecainide. 4 (15) sotalol. |
28 (72) deliveries. |
Castrini et al 38 | 2018 | 58 | 88 | 6 (10) | 15 (26) syncope. 1 (2) dizziness. |
22 (38) VA. |
0 | 6 (7) | 0 | NA | 5 (9) | NA | 16 (28) |
Gandjbakhch et al 39 | 2018 | 23 | 60, 50 completed | 9 (39) | 2 (9) dizziness. | 1 (4) VT. 1 (4) undocumented tachycardia. |
0 | 8 (16) | 0 | 0 | 6 (26) BB only | 2 (8) flecainide only. 5 (22) BB+flecainide. |
Four during follow-up. |
Billebeau et al 7 | 2018 | 3 | 3 | NA | NA | 1 (33) VT. | 0 | NA | 0 | NA | NA | 1 (33) flecainide+catheter ablation. | NA |
All values are n (%).
BB, beta-blocker; CS, caesarean section; HF, heart failure; ICD, implantable cardioverter defibrillator; NA, not available; SVA, sustained ventricular tachycardia, aborted sudden cardiac death or appropriate implantable cardioverter defibrillator (ICD) intervention; VA, ventricular arrhythmia; VES, ventricular extra systole; VT, ventricular tachycardia.